Lebanon, New Hampshire-based biotech company Avitide Inc has named Scott Kennedy as chief financial officer and Karol Lacki as vice president of technology development. Previously, Kennedy was vice president and CFO of PerkinElmer's life sciences solutions division while Lacki worked at Novo Nordisk. Avitide's backers include Polaris Venture Partners, OrbiMed Advisors, Mithril Capital Management, SV Life Sciences, NeoMed Management and Borealis Ventures.
Avitide is a New Hampshire-based biotechnology company that develops and commercializes demand-driven affinity purification solutions for the pharmaceutical industry.